PNC Financial Services Group’s LAVA Therapeutics LVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $85.8K | Hold |
65,000
| – | – | ﹤0.01% | 2813 |
|
|
2025
Q1 | $82.6K | Hold |
65,000
| – | – | ﹤0.01% | 2794 |
|
|
2024
Q4 | $61.8K | Hold |
65,000
| – | – | ﹤0.01% | 2968 |
|
|
2024
Q3 | $108K | Hold |
65,000
| – | – | ﹤0.01% | 2625 |
|
|
2024
Q2 | $117K | Hold |
65,000
| – | – | ﹤0.01% | 2529 |
|
|
2024
Q1 | $216K | Hold |
65,000
| – | – | ﹤0.01% | 2119 |
|
|
2023
Q4 | $103K | Hold |
65,000
| – | – | ﹤0.01% | 2589 |
|
|
2023
Q3 | $95.6K | Hold |
65,000
| – | – | ﹤0.01% | 2595 |
|
|
2023
Q2 | $132K | Buy |
65,000
+15,000
| +30% | +$30.5K | ﹤0.01% | 2471 |
|
|
2023
Q1 | $83K | Hold |
50,000
| – | – | ﹤0.01% | 2686 |
|
|
2022
Q4 | $175K | Buy |
+50,000
| New | +$175K | ﹤0.01% | 2214 |
|